^
    11ms
    A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors (clinicaltrials.gov)
    P1, N=60, Not yet recruiting, FBD Biologics Limited
    New P1 trial • Metastases
    |
    HCB101